期刊文献+

替比夫定少见不良反应:横纹肌溶解症 被引量:40

An unusual reaction to telbivudine:rhabdomyolysis
原文传递
导出
摘要 1例26岁男性患者,因双下肢肌痛、胸闷和心悸入院治疗。患者入院时尿少,呈酱油色,BP 80/50 mm Hg,HR 120次/min。实验室检查:CK906 U/L,CK-MB 100 U/L,ALT310 U/L,AST369 U/L;尿常规:WBC 1 493.2/μl,RBC 193.1/μl,管型65/μl,病理性管型(+),胆红素(++),潜血(++),蛋白(++),比重1.030;血气分析:pH值6.9,PO264 mm Hg。考虑为代谢性酸中毒,给予5%碳酸氢钠静脉滴注。追问病史,患者有慢性乙型肝炎史,并服用替比夫定600 mg,1次/d,共11个月余。查血肌红蛋白>500 ng/ml,诊断为替比夫定相关横纹肌溶解症。给予血液滤过,甲泼尼龙及其他对症治疗,并停用替比夫定,改为恩替卡韦。住院第2天,患者CK峰值为1300 U/L,CK-MB 61 U/L,ALT512 U/L,AST579 U/L。4 d后尿量恢复正常,肾功能逐渐恢复正常。住院第12天,患者双下肢肌痛明显好转,四肢肌力达Ⅳ级,CK 144 U/L,CK-MB 15.1 U/L,ALT57 U/L,AST34 U/L,电解质正常。 A 26-year-old man was hospitalized with myalgia in his lower extremities, chest distress and palpitation. On admission, he had oliguria, dark urine, a BP of 80/50 mm Hg, and a heart rate of 120 beats/min. Laboratory test results were as follows: CK 906 U/L, CK-MB 100 U/L, ALT 310 U/L, AST 369 U/L. Urinalysis revealed the following results: WBC count 1493.2μl, RBC count 193. 1/μl, cast 65/μl , pathologic cast ( + ), bilirubin ( + + ), occult blood ( + + ), protein ( + + ), specific gravity 1. 030. Blood gas analysis revealed a pH of 6.9 and a PO2 of 64 mm Hg, which was considered to be metabolic acidosis. An IV infusion of sodium bicarbonate 5% was given. A review of his medical history showed that he had a history of chronic hepatitis B and received telbivudine 600 mg once daily for 11 months and more. Laboratory test showed his blood myoglobin level was more than 500 ng/ml. The man was diagnosed with telbivudine-associated rhabdomyolysis and treated with hemofihration, methylprednisolone, and symptomatic therapy. Telbivudine was discontinued and changed to entecavir. The second day of hospitalisation, he had a peak CK level of 1300 U/L, a CK-MB level of 61 U/L, a ALT level of 512 U/L, and a AST level of 579 U/L. Four days later, his urine volume normalized, renal function gradually returned to within normal ranges. On day 12 of hnspitalisation, his myalgia in the lower extremities markedly improved and his muscle strength recovered to grade Ⅳ ; he had a CK level of 144 U/L, a CK-MB level of 15.1 U/L, a ALT level of 57 U/L, a AST level of 34 U/L, and normal electrolyte levels.
出处 《药物不良反应杂志》 2009年第3期201-203,共3页 Adverse Drug Reactions Journal
关键词 替比夫定 不良反应 肌酸激酶 横纹肌溶解综合征 telbivudine adverse reactions creatine kinase rhabdomyolysis
  • 相关文献

参考文献4

二级参考文献34

  • 1朱玫.抗乙肝病毒治疗对自然病程的影响[J].肝脏,2007,12(S1):33-36. 被引量:6
  • 2汪月娥.耐药所致治疗失效的临床结局[J].肝脏,2007,12(S1):37-39. 被引量:5
  • 3庄辉.病毒性肝炎的流行病学[J].中国计划免疫,2004,10(3):180-181. 被引量:64
  • 4江骥,胡蓓,王洪允,沈凯,Nathaniel A.Brown,周晓剑.替比夫定的药代动力学研究[J].中华肝脏病杂志,2006,14(11):811-813. 被引量:8
  • 5贾继东,侯金林,尹有宽,徐道振,谭德明,牛俊奇,周霞秋,王宇明,朱理珉,贺永文,任红,万谟彬,陈成伟,巫善明,陈亚岗,许家璋,王勤环,魏来,马红.替比夫定或拉米夫定抗乙型肝炎病毒的疗效预测探讨[J].中华肝脏病杂志,2007,15(5):342-345. 被引量:141
  • 6[1]Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysis[J]. Medicine, 1982, 61(3):141-152.
  • 7[3]Veenstra J, Smith WM, Krediet RT, et al. Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis [J]. Nephrol Dial Transplant,1994,9(6): 637-641.
  • 8[4]Ward MM. Factors predictive of acute renal failure in rhabdomyolysis[J]. Arch Intern Med, 1988, 148(7):1553-1557.
  • 9[5]Burl RD. Acute renal failure associated with pigmenturia or crystal deposits[A]. In: Robert W, eds. Diseases of the Kidney[M]. Six ed . New York: Little Brown and company. 1996.1273-1282.
  • 10[6]Cooper PN, Tapson J, Morley AR, et al. Immunoperoxidase techniques and histology in the diagnosis of rhabdomyolysis related acute renal failure [J]. J Clin Pathol,1992, 45(9): 825-827.

共引文献57

同被引文献338

引证文献40

二级引证文献262

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部